Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_4
3
38%
Ph phase_3
3
38%
Ph not_applicable
2
25%

Phase Distribution

0

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
3(37.5%)
Phase 4Post-market surveillance
3(37.5%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (37.5%)
Phase 43 (37.5%)
N/A2 (25.0%)

Trials by Status

completed675%
unknown113%
withdrawn113%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_4

RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department

NCT04485195
unknownphase_4

Prevention of Post-Operative Cardiac Arrhythmias

NCT04234906
withdrawnnot_applicable

Acute Mechanical Response to Anti-arrhythmic Drug Therapy

NCT02575534
completednot_applicable

ST-segment Elevation as an AF Endophenotype

NCT01205529
completedphase_3

Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)

NCT00000556
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT04485195Phase 4

RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department

Completed
NCT04234906Phase 4

Prevention of Post-Operative Cardiac Arrhythmias

Unknown
NCT02575534Not Applicable

Acute Mechanical Response to Anti-arrhythmic Drug Therapy

Withdrawn
NCT01205529Not Applicable

ST-segment Elevation as an AF Endophenotype

Completed
NCT00000556Phase 3

Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)

Completed
NCT00000518Phase 3

Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)

Completed
NCT00000464Phase 3

Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)

Completed
NCT00702117Phase 4

Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8